Purchase Order VA580Q15400
Award Date
5/3/11
Potential Completion Date
6/3/11
Potential Value
$7.1K
Federal Agency
Veterans Integrated Service Network 17
Awardee
Regenesis Biomedical Inc.
Ultimate Awardee
Not listed
NAICS Category
339112 - Surgical and Medical Instrument Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Scottsdale, AZ 85257, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Department of Veterans Affairs (VA) to Regenesis Biomedical Inc., a private medical technology company. The $7,055.10 firm-fixed-price purchase order is for the provision of the Provant Therapy System, a patented noninvasive regenerative medicine product developed by Regenesis Biomedical. The contract, which does not utilize any set-aside, is awarded against Regenesis Biomedical's GSA Schedule 65-II-A contract for medical equipment and supplies. The...
This federal contract award to Regenesis Biomedical Inc. is for the supply of the company's Provant Therapy System medical device and related rental/leasing services to the U.S. Department of Veterans Affairs (VA). The $4,882.79 firm-fixed-price purchase order was awarded on February 16, 2011, with a completion date of March 16, 2011. The contract was awarded against Regenesis Biomedical's existing General Services Administration (GSA) Schedule 65-II-A contract for medical equipment and...
This federal contract award was issued by the Department of Veterans Affairs (VA) to Regenesis Biomedical Inc., a privately held medical technology company, for the provision of the Provant Therapy System, a noninvasive regenerative medicine product. The $4,820.98 firm-fixed-price purchase order contract was awarded on January 10, 2011, with a completion date of February 10, 2011. The contract was awarded under Regenesis Biomedical's General Services Administration (GSA) Schedule 65-II-A for...
This federal contract award is for the Department of Veterans Affairs (VA) to procure the Provant Therapy System and associated rental services from Regenesis Biomedical Inc. The $3,645.14 firm fixed-price purchase order was issued under Regenesis Biomedical's GSA Schedule 65-II-A contract for medical equipment and supplies. The Provant Therapy System is Regenesis Biomedical's patented non-invasive regenerative medicine product, indicated for palliative treatment of post-operative pain and...
This federal contract award was made by the Department of Veterans Affairs (VA) to Regenesis Biomedical Inc., a medical technology company, to provide the Provant Therapy System and related rental services. The $7,145.56 firm-fixed-price purchase order contract has an ultimate completion date of February 24, 2011. Regenesis Biomedical Inc. is the prime contractor and does not utilize any subcontractors for this work. The contract is not associated with any set-aside program. The Provant...
This federal contract award was issued by the Department of Veterans Affairs (VA) to Regenesis Biomedical Inc., a privately held medical technology company. The $4,820.98 firm fixed-price purchase order is for the Provant Therapy System, a noninvasive regenerative medicine product indicated for the palliative treatment of post-operative pain and edema. The contract has an ultimate completion date of January 20, 2011. Regenesis Biomedical has provided the Provant Therapy System and related rental...
This federal contract award was made by the Department of Veterans Affairs (VA) to Regenesis Biomedical Inc., a privately held medical technology company. The $7,142.85 firm fixed-price purchase order contract is for the provision of Regenesis Biomedical's Provant Therapy System, a patented noninvasive regenerative medicine product indicated for the palliative treatment of post-operative pain and edema. The contract is not associated with any set-aside designations. Regenesis Biomedical,...
This federal contract award was issued by the Department of Veterans Affairs (VA) to Regenesis Biomedical Inc., a privately held medical technology company. The $4,820.98 firm-fixed-price purchase order is for the company's Provant Therapy System, a noninvasive regenerative medicine product indicated for the palliative treatment of post-operative pain and edema. The contract has an ultimate completion date of May 8, 2011 and was awarded through Regenesis Biomedical's existing GSA Schedule...
This federal contract award to Regenesis Biomedical Inc. is a Purchase Order from the Department of Veterans Affairs (VA) for the company's Provant Therapy System, a non-invasive regenerative medicine product. The $4,820.98 Firm Fixed Price contract is for the supply of the Provant Therapy System devices and related rental/leasing services to VA medical facilities. The award appears to be part of Regenesis Biomedical's existing General Services Administration (GSA) Schedule 65-II-A contract...
This federal contract award, valued at $7,145.55, was issued by the Department of Veterans Affairs (VA) to Regenesis Biomedical Inc., a private medical technology company. The contract is for the provision of Regenesis Biomedical's proprietary Provant Therapy System, a non-invasive regenerative medicine product indicated for the palliative treatment of post-operative pain and edema. This contract appears to be a purchase order under Regenesis Biomedical's existing GSA Schedule 65-II-A contract...